Clinical Trial Update: A Study of Lanabecestat (LY3314814) in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial update of lanabecestat (LY3314814) in healthy participants; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• lanabecestat (lanabecestat)

Snippet

Sponsor: AstraZeneca | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2019-03-22